SBI Term Loan: RLLR: 8.15 | 7.25% - 8.45%
Canara Bank: RLLR: 8 | 7.15% - 10%
ICICI Bank: RLLR: -- | 8.5% - 9.65%
Punjab & Sind Bank: RLLR: 7.3 | 7.3% - 10.7%
Bank of Baroda: RLLR: 7.9 | 7.2% - 8.95%
Federal Bank: RLLR: -- | 8.75% - 10%
IndusInd Bank: RLLR: -- | 7.5% - 9.75%
Bank of Maharashtra: RLLR: 8.05 | 7.1% - 9.15%
Yes Bank: RLLR: -- | 7.4% - 10.54%
Karur Vysya Bank: RLLR: 8.8 | 8.5% - 10.65%

SAT grants temporary relief to Omaxe in SEBI securities market ban

#Taxation & Finance News#India
Last Updated : 14th Oct, 2024
Synopsis

The Securities Appellate Tribunal (SAT) stayed a Securities and Exchange Board of India (SEBI) order barring Omaxe and its top executives from the securities market for two years due to financial misrepresentation. The stay allows Omaxe to raise capital and continue operations. SEBI's initial ruling included a penalty of INR47 lakh for Omaxe and several individuals involved in a fraudulent scheme, which misrepresented financial activities over three fiscal years.

The Securities Appellate Tribunal (SAT) has temporarily halted a Securities and Exchange Board of India (SEBI) order that barred real estate firm Omaxe, along with its Chairman Rohtas Goel and Managing Director Mohit Goel, from participating in the securities market for two years due to misrepresentation in the company's financial statements. This decision followed an appeal by Omaxe and the involved parties against the SEBI ruling issued on July 30.


In its ruling earlier this week, the appellate tribunal stated that the restrictions detailed in paragraphs No. 41(1) and (2) would remain suspended, provided the appellant deposits the penalty amount within four weeks. These paragraphs relate to the ban on securities market participation and prohibition from holding any key managerial positions in other listed companies imposed on the individuals by SEBI.

Commenting on this development, Omaxe's Managing Director Mohit Goel expressed that the stay on restrictions has lifted the barriers to their involvement in the securities market, allowing them to raise capital and conduct business operations without interruption. He affirmed to reports at PTI the company's commitment to transparency and maintaining the trust of investors and stakeholders, emphasising their cooperation with authorities and focus on ongoing projects for sustained growth.

SEBI's original ruling had prohibited Omaxe, Rohtas Goel, Mohit Goel, and three others-Sudhangshu S Biswal, Arun Kumar Pandey, and Vimal Gupta-from the securities markets for a duration of two years. Additionally, these individuals were barred from holding any director or key managerial roles in other listed companies for the same period. A total penalty of INR47 lakh was levied on 16 entities, with individual penalties ranging from INR1 lakh to INR7 lakh.

According to SEBI, these entities acted in concert to execute a fraudulent scheme, misrepresenting transactions as normal activities despite the company facing losses, which they attempted to disguise as mere lending to sustain Omaxe's stock price over three years. The financial statements for the years 2018-19, 2019-20, and 2020-21 were allegedly manipulated, affecting various financial indicators such as revenue, debtors, advances, and expenses.

SEBI noted that the extensive misrepresentation led to direct or indirect manipulation of the stock price, ultimately misleading shareholders and investors, preventing them from making informed decisions regarding their investments in Omaxe.

In conclusion, this stay marks a significant development for Omaxe, enabling the company to resume its activities in the securities market. With a renewed focus on transparency and cooperation with regulatory authorities, Omaxe aims to restore investor confidence while addressing past issues. The outcome of the ongoing proceedings will be crucial for the firm's future and its commitment to ethical business practices.

Have something to say? Post your comment